[go: up one dir, main page]

GB1037155A - Diagnostic agents for the detection of components contained in full blood - Google Patents

Diagnostic agents for the detection of components contained in full blood

Info

Publication number
GB1037155A
GB1037155A GB1174565A GB1174565A GB1037155A GB 1037155 A GB1037155 A GB 1037155A GB 1174565 A GB1174565 A GB 1174565A GB 1174565 A GB1174565 A GB 1174565A GB 1037155 A GB1037155 A GB 1037155A
Authority
GB
United Kingdom
Prior art keywords
impregnated
amino acid
test paper
blood
observed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1174565A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of GB1037155A publication Critical patent/GB1037155A/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5002—Partitioning blood components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • C12Q1/46—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase involving cholinesterase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/521—Single-layer analytical elements

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

Abstract

An absorbent test paper which is wholly or partially impregnated with one or more reagents and indicators for diagnosing components in full blood is either in the case of partial impregnation impregnated at the other end with, or in the case of whole impregnation in association with another test paper impregnated with, an amino acid, an amino acid amide or a salt thereof which gives a separation of red blood substance from only slightly coloured blood fluids so that the colour reaction of an area only coloured by the fluids can be observed. The reagent and indicator test paper may be covered on one side by a paper impregnated with an amino acid and on the other side by a transparent, heat-sealable water insoluble synthetic resin, through which the colour reaction can be observed. Glycocoll, alamine, glycinamide, asparafine and glutamine are given as examples of aminoacids and aminoacid amides.
GB1174565A 1964-03-20 1965-03-19 Diagnostic agents for the detection of components contained in full blood Expired GB1037155A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB0075999 1964-03-20

Publications (1)

Publication Number Publication Date
GB1037155A true GB1037155A (en) 1966-07-27

Family

ID=6978898

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1174565A Expired GB1037155A (en) 1964-03-20 1965-03-19 Diagnostic agents for the detection of components contained in full blood

Country Status (6)

Country Link
AT (1) AT255660B (en)
CH (1) CH471385A (en)
DK (1) DK119439B (en)
ES (1) ES310641A1 (en)
GB (1) GB1037155A (en)
LU (1) LU48224A1 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4426451A (en) 1981-01-28 1984-01-17 Eastman Kodak Company Multi-zoned reaction vessel having pressure-actuatable control means between zones
US4478944A (en) * 1982-11-24 1984-10-23 Eastman Kodak Company Analytical element containing a barrier zone and process employing same
EP0133895A1 (en) * 1983-07-02 1985-03-13 Roche Diagnostics GmbH Substrate for retaining erythrocytes
US5526120A (en) * 1994-09-08 1996-06-11 Lifescan, Inc. Test strip with an asymmetrical end insuring correct insertion for measuring
US5563042A (en) 1986-08-13 1996-10-08 Lifescan, Inc. Whole blood glucose test strip
US5563031A (en) * 1994-09-08 1996-10-08 Lifescan, Inc. Highly stable oxidative coupling dye for spectrophotometric determination of analytes
US5780304A (en) * 1994-09-08 1998-07-14 Lifescan, Inc. Method and apparatus for analyte detection having on-strip standard
US6335203B1 (en) 1994-09-08 2002-01-01 Lifescan, Inc. Optically readable strip for analyte detection having on-strip orientation index
US6458326B1 (en) 1999-11-24 2002-10-01 Home Diagnostics, Inc. Protective test strip platform
US6525330B2 (en) 2001-02-28 2003-02-25 Home Diagnostics, Inc. Method of strip insertion detection
US6541266B2 (en) 2001-02-28 2003-04-01 Home Diagnostics, Inc. Method for determining concentration of an analyte in a test strip
US6562625B2 (en) 2001-02-28 2003-05-13 Home Diagnostics, Inc. Distinguishing test types through spectral analysis
RU2271001C1 (en) * 2004-06-21 2006-02-27 Лидия Васильевна Савина Express method for identifying pharmaceutics and parapharmaceutics introduced into human organism

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4426451A (en) 1981-01-28 1984-01-17 Eastman Kodak Company Multi-zoned reaction vessel having pressure-actuatable control means between zones
US4478944A (en) * 1982-11-24 1984-10-23 Eastman Kodak Company Analytical element containing a barrier zone and process employing same
EP0133895A1 (en) * 1983-07-02 1985-03-13 Roche Diagnostics GmbH Substrate for retaining erythrocytes
US6821483B2 (en) 1986-08-13 2004-11-23 Lifescan, Inc. Reagents test strip with alignment notch
US6887426B2 (en) 1986-08-13 2005-05-03 Roger Phillips Reagents test strip adapted for receiving an unmeasured sample while in use in an apparatus
US5563042A (en) 1986-08-13 1996-10-08 Lifescan, Inc. Whole blood glucose test strip
US6881550B2 (en) 1986-08-13 2005-04-19 Roger Phillips Method for the determination of glucose employing an apparatus emplaced matrix
US5843692A (en) 1986-08-13 1998-12-01 Lifescan, Inc. Automatic initiation of a time interval for measuring glucose concentration in a sample of whole blood
US6268162B1 (en) 1986-08-13 2001-07-31 Lifescan, Inc. Reflectance measurement of analyte concentration with automatic initiation of timing
US6858401B2 (en) 1986-08-13 2005-02-22 Lifescan, Inc. Minimum procedure system for the determination of analytes
US5563031A (en) * 1994-09-08 1996-10-08 Lifescan, Inc. Highly stable oxidative coupling dye for spectrophotometric determination of analytes
US6491870B2 (en) 1994-09-08 2002-12-10 Lifescan, Inc. Optically readable strip for analyte detection having on-strip orientation index
US6335203B1 (en) 1994-09-08 2002-01-01 Lifescan, Inc. Optically readable strip for analyte detection having on-strip orientation index
US5780304A (en) * 1994-09-08 1998-07-14 Lifescan, Inc. Method and apparatus for analyte detection having on-strip standard
US5526120A (en) * 1994-09-08 1996-06-11 Lifescan, Inc. Test strip with an asymmetrical end insuring correct insertion for measuring
US6458326B1 (en) 1999-11-24 2002-10-01 Home Diagnostics, Inc. Protective test strip platform
US6979571B2 (en) 1999-11-24 2005-12-27 Home Diagnostics, Inc. Method of using a protective test strip platform for optical meter apparatus
US6525330B2 (en) 2001-02-28 2003-02-25 Home Diagnostics, Inc. Method of strip insertion detection
US6541266B2 (en) 2001-02-28 2003-04-01 Home Diagnostics, Inc. Method for determining concentration of an analyte in a test strip
US6562625B2 (en) 2001-02-28 2003-05-13 Home Diagnostics, Inc. Distinguishing test types through spectral analysis
US7390665B2 (en) 2001-02-28 2008-06-24 Gilmour Steven B Distinguishing test types through spectral analysis
RU2271001C1 (en) * 2004-06-21 2006-02-27 Лидия Васильевна Савина Express method for identifying pharmaceutics and parapharmaceutics introduced into human organism

Also Published As

Publication number Publication date
AT255660B (en) 1967-07-10
DE1498601A1 (en) 1969-04-03
DK119439B (en) 1971-01-04
CH471385A (en) 1969-04-15
ES310641A1 (en) 1965-07-01
DE1498601B2 (en) 1972-11-02
LU48224A1 (en) 1965-05-19

Similar Documents

Publication Publication Date Title
GB1037155A (en) Diagnostic agents for the detection of components contained in full blood
ES445808A1 (en) PROCEDURE FOR THE PREPARATION OF AGENTS FOR DIAGNOSIS, FOR THE DETECTION OF ALBUMIN IN BODY LIQUIDS.
GB1511902A (en) Organ function test cards
GB772374A (en) Blood test
DE3679134D1 (en) DIAGNOSTIC SYSTEM FOR DETECTING DEFECTIVE SENSORS IN AN AIR CONDITIONING PROVIDED WITH A LIQUID COOLER.
IE872155L (en) Indicator device
ATE24054T1 (en) MEASURING EQUIPMENT FOR MEASUREMENT OF THE DEFORMATION CAPACITY OF RED BLOOD CELLS.
GB1274617A (en) Indicator devices
AT317441B (en) Indicator substances for the detection of urobilinogen
US3022141A (en) Small testing tubes having three or more separately arranged reagents or reagent layers
NZ179837A (en) Fluorimetric assay of reduced coenzyme in aqueous systems:diagnostic test kits
CH442878A (en) Ball joint, particularly for use in motor vehicles, with a bellows-like seal for the outlet opening of the joint housing for the joint pin
DE3771019D1 (en) DEVICE FOR MEASURING FLOW VECTORS IN GAS FLOWS.
ES309450A1 (en) Diagnostic test method to determine the ovulatory function. (Machine-translation by Google Translate, not legally binding)
FR2233024A1 (en) Treponema haemagglutination test - using tanned avian erythrocytes as carrier for ireponema antigen
JPS5292773A (en) Automatic analyzer
AR208059A1 (en) A TEST DEVICE USED IN THE QUALITATIVE AND QUANTITATIVE DETERMINATION OF CATALASE IN MILK AND OTHER LIQUIDS, MAINLY OF BIOLOGICAL ORIGIN
KR960706073A (en) Blood component detection method and kit for use
GB1219555A (en) Colorimetric reagent
BE610922A (en) Methods for determining the amino content of aqueous liquids
IL47736A (en) Diagnostic test system for detecting the presence of specific viral antibodies in body fluids
GB1283782A (en) Indicator dyes for pregnancy detection
Shrivastava et al. Effect of mixing on BOD test
DD129579B1 (en) DETECTION OF HARN PATHOGENIC BACTERIA BY ELECTRO-CHEMICAL MEASUREMENT OF THE OXYGEN AND CARBON DIOXIDE CONTENT IN THE HARN
IL35517A0 (en) Diagnostic test procedure and test reagents for the detection of hepatitis